Michael Faerm

Michael Faerm

Nessuna posizione attualmente
59 anni
Health Technology
Finance
Consumer Services

Profilo

Michael E.
Faerm
is currently Chief Financial Officer at Atai Beckley, Inc. since 2026.
Former positions include Chief Financial Officer at Harpoon Therapeutics, Inc. from 2023 to 2024, Chief Financial & Accounting Officer at Viracta Therapeutics, Inc. from 2024 to 2025, Chief Financial Officer at Artiva Biotherapeutics, Inc. from 2021 to 2023, Chief Business Officer & Senior Vice President at Innoviva, Inc. from 2015 to 2018, Vice President at Merrill Lynch & Co., Inc. in 2000, Associate Director at Forest Laboratories, Inc. in 2006, Associate Director at Regeneron Pharmaceuticals, Inc. in 2004, Analyst at Credit Suisse Securities (USA) LLC from 2011 to 2013, and Analyst at Wells Fargo Securities LLC.
Education includes undergraduate studies at The Trustees of Columbia University in The City of New York, graduate studies at Stanford University, and an MBA from Harvard Business School.

Posizioni attive di Michael Faerm

SocietàPosizioneInizio

Precedenti posizioni note di Michael Faerm

SocietàPosizioneFine
VIRACTA THERAPEUTICS, INC. Direttore Finanziario/CFO 05/02/2025
HARPOON THERAPEUTICS, INC. Direttore Finanziario/CFO 01/03/2024
ARTIVA BIOTHERAPEUTICS, INC. Direttore Finanziario/CFO 01/03/2023
INNOVIVA, INC. Corporate Officer/Principal 07/02/2018
FOREST LABORATORIES, INC. Corporate Officer/Principal 01/01/2006
Vedi nel dettaglio l'esperienza di Michael Faerm

Formazione di Michael Faerm

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

64

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Finance

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Finance

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Michael Faerm